Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_1
2
40%
Ph phase_2
3
60%

Phase Distribution

2

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
3(60.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Terminated(1)

Detailed Status

Completed4
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (40.0%)
Phase 23 (60.0%)

Trials by Status

completed480%
terminated120%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_2

Feasibility And Safety Study Of rhBMP-2/CPM For Hip Fractures

NCT00384358
completedphase_2

A Study of rhBMP-2/CPM in Closed Fractures of the Humerus

NCT00384852
terminatedphase_2

A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures

NCT00387686
completedphase_1

Study Evaluating rhBMP-2/CPM in Closed Distal Radius Fractures

NCT00161629
completedphase_1

Study Evaluating rhMBP-2/CPM in Open Wedge Osteotomies

NCT00243295

Clinical Trials (5)

Showing 5 of 5 trials
NCT00384358Phase 2

Feasibility And Safety Study Of rhBMP-2/CPM For Hip Fractures

Completed
NCT00384852Phase 2

A Study of rhBMP-2/CPM in Closed Fractures of the Humerus

Completed
NCT00387686Phase 2

A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures

Terminated
NCT00161629Phase 1

Study Evaluating rhBMP-2/CPM in Closed Distal Radius Fractures

Completed
NCT00243295Phase 1

Study Evaluating rhMBP-2/CPM in Open Wedge Osteotomies

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5